Pharmaceutical Industry Blog

Ribociclib is a targeted therapy designed to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative...

Polatuzumab is a targeted radioimmunotherapy designed to treat various blood cancers, including diffuse large B-cell lymphoma (DLBCL) and...

Alemtuzumab is a monoclonal antibody designed to treat multiple sclerosis (MS) and certain types of leukemia, particularly B-cell chronic...

Margetuximab is a chimeric IgG monoclonal antibody that targets the HER2 protein, offering a new treatment option for patients with...

Ibalizumab is a monoclonal antibody designed to treat HIV-1 infection. This innovative therapy offers a new approach to managing HIV by...

Disitamab Vedotin is a novel antibody-drug conjugate (ADC) designed for the treatment of various solid tumors. This innovative therapy...